# A Drug-drug Interaction Study With TS-172 in Healthy Adult Male Subjects

> **NCT06837142** · PHASE1 · COMPLETED · sponsor: **Taisho Pharmaceutical Co., Ltd.** · enrollment: 30 (actual)

## Conditions studied

- Healthy Male Subjects

## Interventions

- **DRUG:** Triazolam and TS-172
- **DRUG:** TS-172 and itraconazole

## Key facts

- **NCT ID:** NCT06837142
- **Lead sponsor:** Taisho Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-11
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-04-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06837142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06837142, "A Drug-drug Interaction Study With TS-172 in Healthy Adult Male Subjects". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06837142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*